is tirzepatide on shortage list Lilly's Could Land Again FDA Drug List, Opens Door for Compounders Lilly's weight-loss drug removed from

It is a stimulant and is contraindicated with cardiovascular disease, uncontrolled high blood pressure, and hyperthyroidism, which is why ongoing physician monitoring is important

Refunds are not typically offered, and GLP1 medication purchases are handled separately by insurers or cash for Zepbound

Side effects that may impact users long-term include thyroid cancer, vision and mental health changes and gastrointestinal issues

Zepbound, a brand name of tirzepatide, is FDA-approved for weight management when combined with increased physical activity and a reduced-calorie diet in adults with: Obesity (BMI 30 or higher) Overweight (BMI 27 or higher with at least one weight-related condition such as high cholesterol levels, hypertension (high blood pressure), type 2 diabetes, and cardiovascular disease Moderate to severe obstructive sleep apnea (OSA) Mounjaro contains tirzepatide as an active ingredient and is approved by the U.S